Medical and compliance record for Alibi Idiris: 1 anti-doping sanction, 1 post-fight medical suspension, 2 anti-doping testing entries. Every entry is dated and linked to its source.
This page reproduces publicly reported regulatory and medical-administrative records. Every entry names the body that issued it. Anti-doping testing entries are counts of publicly reported test sessions and are not pass/fail results — a test session is not a positive test. Records are reproduced as published and are not medical advice.
1Anti-doping sanctions
1Medical suspensions
0Injury records
2Testing entries
Anti-doping sanction (1)
Anti-doping suspension / ineligibility
Anti-doping sanction
Idiris tested positive for the presence of hydrochlorothiazide, a prohibited at all times diuretic in the Diuretics and Masking Agents class of the UFC Prohibited List, from an in-competition sample collected on February 21, 2026, in Houston, Texas, surrounding the UFC Fight Night card in said location. Idiris was victorious in his fight that night against Ode Osborne.
Upon notification of this adverse finding, Idiris has been fully cooperative with CSAD. Idiris provided information that he took a product that contained hydrochlorothiazide on Thursday of fight week to help him make the contracted weight on Friday, February 20, 2026, at the event’s official weigh in. Although Idiris has been fully cooperative with CSAD, CSAD is not suspending or reducing any period of his ineligibility due to the seriousness of knowingly using a diuretic during fight week and the advantage that he received in making his contracted weight. Idiris’s suspension began on February 21, 2026, the day he provided his adverse, in-competition biological sample. His suspension will terminate on February 21, 2027.
Additionally, the Texas Department of Licensing and Regulations (TDLR), who regulated Idiris’ fight on February 21, 2026, where he tested positive in-competition, also retains jurisdiction over this matter and will separately adjudicate Idiris’ adverse finding under TDLR rules. Because hydrochlorothiazide is also a prohibited substance under TDLR rules, TDLR will be responsible for amending the result of Idiris’ fight against Osborne. CSAD has provided all relevant information concerning this case to TDLR.
Date
31 March 2026
Status
Suspended / sanctioned
Suspension length
Twelve Month
Period start
21 February 2026
Issuing body
Combat Sports Anti-Doping (CSAD)
Issued by: Combat Sports Anti-Doping (CSAD)
Post-fight medical suspension (1)
Routine commission clearance requirements issued after a bout. These imply no wrongdoing.
Post-fight regulatory suspension
Post-fight medical suspension
The commission listed this fighter's post-event suspension as until 2026-05-22 (90 days after event).
Date
21 February 2026
Status
Commission suspension
Suspension length
Until 2026-05-22 (90 days after event)
Period end
22 May 2026
Timing
After fight
Event
UFC Fight Night
Opponent
Ode Osbourne
Issuing body
Texas Department of Licensing and Regulation
Issued by: Texas Department of Licensing and Regulation
Anti-doping testing activity (2)
2026 UFC ADP testing activity
Anti-doping testing activity
4 publicly reported test sessions in 2026. This count is not a pass/fail result.
Date
2026
Status
Testing activity
Test sessions reported
4
Issuing body
UFC Anti-Doping Program / CSAD
Issued by: UFC Anti-Doping Program / CSAD
2025 UFC ADP testing activity
Anti-doping testing activity
2 publicly reported test sessions in 2025. This count is not a pass/fail result.